Aurobindo Pharma Ltd Quarterly Results

Gross Sales

8,381.12

7,893.15

7,646.21

7,457.65

7,491.92

Excise Duty

0

0

0

0

0

Net Sales

8,381.12

7,893.15

7,646.21

7,457.65

7,491.92

Other Operating Income

1

85.37

149.86

109.37

88.23

Other Income

134.81

158.88

136.3

220.93

135.62

Total Income

8,516.93

8,137.4

7,932.37

7,787.95

7,715.77

Total Expenditure

6,622.39

6,400.54

6,229.93

5,948.84

6,042.11

PBIDT

1,894.54

1,736.86

1,702.44

1,839.11

1,673.66

Interest

115.02

118.48

112.7

111.04

89.43

PBDT

1,779.52

1,618.38

1,589.74

1,728.07

1,584.23

Depreciation

444.43

418.53

382.28

404.18

354.33

Minority Interest Before NP

0

0

0

0

0

Tax

430.51

498.07

322.13

449.27

570.64

Deferred Tax

1.75

-143.79

68.38

-43.6

-248.09

Reported Profit After Tax

902.83

845.57

816.95

918.22

907.35

Minority Interest After NP

-0.64

-0.24

-0.43

-1

-1.4

Net Profit after Minority Interest

903.47

845.81

817.38

919.22

908.75

Extra-ordinary Items

0

0

0

0

-65.45

Adjusted Profit After Extra-ordinary item

903.47

845.81

817.38

919.22

974.2

EPS (Unit Curr.)

15.56

14.56

14

15.69

15.51

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

58.08

58.08

58.08

58.59

58.59

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

22.6

22

22.26

24.66

22.33

PBDTM(%)

21.23

20.5

20.79

23.17

21.14

PATM(%)

10.77

10.71

10.68

12.31

12.11